| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $16.9B | $13.4B | $9.1B | $11.0B | $15.0B | $3.4B | $2.2B | $1.5B |
| EPS (Basic) | $10.32 | $8.04 | $5.24 | $6.23 | $8.16 | $1.84 | $1.33 | $0.81 |
| EPS (Diluted) | $10.21 | $7.95 | $5.18 | $6.15 | $8.03 | $1.81 | $1.30 | $0.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1420.3B | $1215.1B | $1193.7B | $1180.2B | $1188.1B | $1115.9B | $895.4B | $853.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $111.7B | $105.4B | $89.2B | $128.1B | $127.7B | $105.7B | — | $87.2B |
| Total Liabilities | $1307.6B | $1109.6B | $1093.7B | $1079.0B | $1081.5B | $1012.7B | $812.7B | $772.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $111.6B | $104.5B | $99.0B | $100.1B | $105.4B | $101.8B | $81.5B | $80.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-17.9B | $1.4B | $-33.5B | $-6.4B | $34.0B | $-25.2B | $40.8B | $7.3B |
| Investing Cash Flow | $-46.8B | $-29.5B | $-3.1B | $-11.6B | $-49.9B | $-37.9B | $-33.6B | $-22.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $67.8B | $46.8B | $-2.7B | $22.7B | $41.5B | $83.8B | $-12.0B | $24.2B |